Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CG5503 immediate-release for acute postoperative pain after total hip replacement
2006-004513-18Phase 3Terminated
- Sponsor
- Johnson & Johnson
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tapentadol in acute postoperative pain (4 arms), sponsored by Johnson & Johnson. Primary endpoints: Sum of pain intensity difference over 48 hours and Safety and tolerability. Started Nov 2006; status: terminated.
02
Drugs
tapentadol
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2006-004513-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004513-18.